EUVIMEDEUVIMED entdecken
Crossref

Levels of Evidence

Randall R. Robey

The ASHA Leader · 2004-04 · 9 (7) · 5-5

DOI: 10.1044/leader.ftr2.09072004.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The ASHA Leader, 2004-04. Verfasst von Randall R. Robey. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

You have accessThe ASHA LeaderFeature1 Apr 2004Levels of Evidence Randall R. Robey Randall R. Robey Google Scholar More articles by this author https://doi.org/10.1044/leader.FTR2.09072004.5 SectionsAbout ToolsAdd to favorites ShareFacebookTwitterLinked In The evidence in evidence-based practice (EBP) may take many forms ranging from expert opinion to meta-analysis. Each form of evidence, though, is not equally persuasive in making the case that a certain clinical procedure should become an aspect of recommended care for members of a certain clinical population. The greater the scientific rigor in producing clinical evidence, the more potent is that evidence for influencing the formation of policies affecting clinical practice. The literature bearing on a certain clinical procedure is inventoried for: the relevance of findings, the quality of findings, the number of findings, and the consistency of findings for establishing a clear and singular linkage between a certain clinical outcome and a certain clinical procedure applied to members of a certain clinical population. The terms “levels of evidence” or “strength of evidence” refer to systems for classifying the evidence in a body of literature through a hierarchy of scientific rigor and quality. Several dozen of these hierarchies exist (Agency for Healthcare Research and Quality [AHRQ], 2002b). Some systems comprise three levels and others eight or more. The gradations in some hierarchies are based on randomization and experimental controls. The organizing focus for others may center on magnitude of effect sizes, confidence intervals, number of results, consistency of results, sample size, or Type I and Type II error rates (AHRQ, 2002a). In each application of EBP process, reviewers must select the most relevant levels-of-evidence system for the type of procedure being assessed (e.g., measurement technologies, diagnosis, prognosis, safety, efficacy, and effectiveness). In the United States, the recognized authority regarding the assessment of scientific clinical research is AHRQ and the system in the “Example Levels of Evidence” table below is one used by AHRQ (2001). Some international organizations adapt AHRQ systems (e.g., Scottish Intercollegiate Guidelines Network); others use wholly different systems (e.g., World Health Organization). Example Levels of Evidence Sources of Evidence, Classification Meta-analysis of multiple well-designed controlled studies, 1A Well-designed randomized controlled trials, 1 Well-designed non-randomized controlled trial (quasi-experiments), 2 Observational studies with controls(retrospective studies, interrupted time-series studies, case-control studies, cohort studies with controls), 3 Observational studies without controls (cohort studies without controls and case series), 4 References Agency for Healthcare Research and Quality. (2001). Making health care safer: A critical analysis of patient safety practices. Evidence Report/Technology Assessment: Number 43.AHRQ Publication No. 01-E058. Rockville, MD: Agency for Healthcare Research and Quality (www.ahrq.gov/clinic/ptsafety/). Google Scholar Agency for Healthcare Research and Quality. (2002a). Rating the strength of scientific research findings. AHRQ Publication No. 02-P022. Rockville, MD: Agency for Healthcare Research and Quality (www.ahrq.gov/clinic/epcsums/strenfact.htm). Google Scholar Agency for Healthcare Research and Quality. (2002b). Systems to rate the strength of scientific evidence. Summary, evidence report/technology assessment: Number 47. AHRQ Publication No. 02-E015. Rockville, MD: Agency for Healthcare Research and Quality (www.ahrq.gov/clinic/epcsums/strengthsum.htm). Google Scholar Author Notes Randall R. Robey, is an associate professor and director of the Communication Disorders Program in the Curry School of Education at the University of Virginia. His research combines two areas of concentration: clinical aphasiology and quantifying valid indices of change brought about by clinical interventions. Contact him by e-mail at [email protected]. Advertising Disclaimer | Advertise With Us Advertising Disclaimer | Advertise With Us Additional Resources FiguresSourcesRelatedDetailsCited ByAmerican Journal of Speech-Language Pathology29:4 (1811-1820)12 Nov 2020The Use of Nonspeech Oral Motor Exercises in the Treatment of Children With Cleft Palate: A Re-Examination of Available EvidenceDennis M. Ruscello and Linda D. VallinoLanguage, Speech, and Hearing Services in Schools42:3 (320-330)1 Jul 2011Guiding Principles and Clinical Applications for Speech-Language Pathology Practice in Early InterventionDine Paul and Froma P. Roth Volume 9Issue 7April 2004 Get Permissions Add to your Mendeley library History Published in print: Apr 1, 2004 Metrics Downloaded 11,841 times Topicsasha-topicsleader_do_tagleader-topicsasha-article-typesCopyright & Permissions© 2004 American Speech-Language-Hearing AssociationLoading ...

Zitieren

APA

Robey, R. R. (2004). Levels of Evidence. The ASHA Leader, 9(7), 5-5. https://doi.org/10.1044/leader.ftr2.09072004.5

Vancouver

Robey RR. Levels of Evidence. The ASHA Leader. 2004;9(7):5-5. doi:10.1044/leader.ftr2.09072004.5

BibTeX
@article{Robey2004,
  author = {Robey, Randall R.},
  title = {Levels of Evidence},
  journal = {The ASHA Leader},
  year = {2004},
  volume = {9},
  number = {7},
  pages = {5--5},
  doi = {10.1044/leader.ftr2.09072004.5}
}
Kostenlos starten →